OBJECTIVE: Several investigators have focused on obesity as a specific risk factor for mortality in patients undergoing bypass surgery, but few have examined it as a risk factor among patients undergoing percutaneous coronary interventions (PCI). In addition, none have evaluated the impact of obesity on post-PCI quality of life or disease-specific health status. This study examined whether obesity is a risk factor for poor quality of life or diminished health status 12-months postprocedure among a large cohort of PCI patients. RESEARCH METHODS AND PROCEDURES: A total of 1631 consecutive PCI patients were enrolled into the study and classified as underweight (BMI o20 kg/m 2 ), normal weight range (BMI Z20 and o25 kg/m 2 ), overweight (BMI Z25 and o30 kg/m 2 ), class I obese (BMI Z30 kg/m 2 ), or class II and III obese (BMI Z35 kg/m 2 ). The 12-month postprocedure outcomes included need for repeat procedure, survival, quality of life and health status, assessed using the Seattle Angina Questionnaire (SAQ) and the Short Form-12. RESULTS: Obese patients with and without a history of revascularization were significantly younger than overweight, normal weight range, or underweight patients at the time of PCI. However, obese patients demonstrated similar long-term recovery and improved disease-specific health status and quality of life when compared to patients in the normal weight range after PCI. In addition, mortality and risk for repeat procedure was similar to those patients in the normal weight range patients at 12-months postrevascularization. Underweight patients who had no previous history of revascularization reported lower quality of life (F ¼ 3.02; P ¼ 0.018) and poorer physical functioning (F ¼ 2.82; P ¼ 0.024) than other BMI groups. CONCLUSION: Obese patients presenting for revascularization were younger when compared to patients in the normal weight range, regardless of previous history of revascularization. However, weight status was not a significant predictor of differences in long-term disease-specific health status, quality of life, repeat procedures, or survival. Underweight patients demonstrated less improvement in quality of life and physical functioning than other BMI groups. International Journal of Obesity (2004) The concern over the rise in
obesity is particularly acute for cardiology, where excess weight has been established as an important contributor cardiovascular risk. [4] [5] Obesity also has been identified as increasing risk for preor postoperative surgical complications among coronary artery bypass graft (CABG) patients. [6] [7] Numerous studies have examined the influence of obesity on CABG outcomes, with a number of studies demonstrating greater risk for surgical complications, and postsurgical morbidity (eg, prolonged total bypass time, anesthesia difficulties, technical difficulties in patients undergoing CABG, postsurgical myocardial infarction, respiratory problems, leg wounds, sternal dehiscence, longer hospital stays and higher cumulative inpatient hospital costs). [8] [9] [10] [11] [12] [13] [14] [15] However, the relationship between obesity and post-CABG mortality is equivocal. [5] [6] 9, 11, [15] [16] [17] [18] Few studies have examined the impact of obesity on outcomes following percutaneous coronary intervention (PCI), which is surprising given that PCI use has increased 262% from 1987 to 2000, is more frequently used than CABG, and is associated with less procedural difficulties. 19 While some investigators have found that increasing BMI is associated with greater post-PCI mortality risk, 20 -21 several others were not able to replicate these findings. [22] [23] [24] In fact, a study pooling data from four randomized trials demonstrated no differences among BMI groups in PCI procedural success rates or risk of early mortality and complications, 24 leading several investigators to propose an 'obesity paradox,' that is, obese patients experiencing reduced postprocedural risk when compared to other weight groups, particularly underweight patients. 18, [20] [21] 24 While the data are meager and inconsistent with regard to obesity-related post-PCI mortality risk, there are no data regarding nonsurvival related outcomes among PCI patients. Since PCI is associated with low mortality risk and is being used with increasingly greater frequency, it is essential that we document the impact of obesity on post-PCI health status (ie, physical functioning, mental health, angina control, or quality of life), which is arguably the most important outcome for patients who have undergone PCI. 25 The purpose of this study was to examine whether obesity, as defined by the WHO 26 and NIH 27 standards, is a risk factor for poor long-term quality of life, greater angina, and diminished disease-specific health status among PCI patients. In addition, because previous revascularization history is a significant moderator of PCI outcomes, 28 patients
were stratified according to their revascularization status.
Methods

Participants
The process of patient recruitment, mechanism, success, and potential selection biases of baseline health status data collection have been previously described. 29 In brief, consecutive patients undergoing PCI from February 1999 through August 2000 were approached to participate in an observational research study documenting the recovery of their health status after coronary revascularization. Each consenting patient was administered a series of questionnaires, including the Seattle Angina Questionnaire (SAQ), at baseline, 6-, and 12-months following PCI. These data were used to supplement an existing database that provided detailed descriptions of their coronary anatomy, the type of revascularization performed, procedural results and postprocedure complications. A minimum of eight attempts to contact patients by phone and two attempts to contact patients by mail were performed to minimize attrition and maximize the generalizability of the study results. 
Long-term health status
Measures. To facilitate a broad outcomes assessment, traditional markers of disease progression, such as mortality and repeat procedures, were supplemented with a robust assessment of health status (including function, symptoms, and quality of life). Specific outcomes assessed included: Disease-specific health status: the Seattle angina questionnaire (SAQ). The SAQ is a valid, reliable, and responsive diseasespecific measure of health status that was established for coronary artery disease patients to assess health-related quality of life. [30] [31] [32] [33] In addition, the SAQ also has been found to predict subsequent mortality, that is, patients with low functional status scores on the SAQ demonstrated significantly greater risk for mortality after 1-year follow-up. 34 Additional reliability and validation studies have been conducted with US and European samples, demonstrating that the SF-12 produces similar reliability and validity coefficients when compared to the SF-36. [36] [37] Finally, the SF-12 has been validated in several unique patient populations including individuals with HIV, stroke, and heart disease and heart failure.
38-41
Repeat procedures and long-term survival. Confirmation of repeat procedures and subsequent hospitalizations were assessed and verified by querying the procedural database and hospital records of the Mid America Heart Institute. Mortality was assessed at 6-and 12 months for patients not interviewed by querying the SSADMF, hospital records, and state vital records.
Statistical analyses
Differences in the distribution of demographic variables by BMI status among PCI patients were analyzed using analysis of variance (ANOVA) for continuous variables or the w 2 test for discrete variables. In addition, patients were stratified according to their revascularization status because previous revascularization has been found to be a significant predictor of PCI outcomes. 28 For all analyses, participants weight classification were as outlined previously. [26] [27] Multivariate logistic regression models were used to evaluate the association between BMI status and need for repeat revascularization and long-term survival (ie, mortality at 12 months). Adjusted ANCOVA models were used to evaluate the impact of BMI category on long-term health outcomes, that is, disease-specific (SAQ) and generic health status (SF-12). All models were adjusted for established risk factors [42] [43] and demographic variables that were found to significantly differ among the BMI categories. They did not differ significantly by ethnicity, BMI, or any comorbidity or disease severity factor (presence of diabetes, stroke, peripheral vascular disease, hypertension, number of diseased vessels, history of previous myocardial infarction, angina stability, whether they had a repeat revascularization within the last 6 months, ejection fraction less than 40%). Table 1 presents information about the baseline characteristics of PCI patients by BMI category. There were significant age differences between the BMI categories for those with and without history of previous revascularization (F ¼ 11.07, Po0.001 for PCI patients with no previous revascularization; F ¼ 27.92, Po0.001 for PCI patients with previous revascularization), even after adjustment for confounds (eg, marital status, gender, hypertension, diabetes, or angina type). Post hoc analysis demonstrated that patients without a history of revascularization and who were classified as class II or III obesity were significantly younger than either class I obesity (P ¼ 0.004), overweight (Po0.001), normal weight range (Po0.001), or underweight patients (Po0.007) at the time of PCI. Similarly, class I and II obese patients with previous history of revascularization also were significantly younger than patients who were class I obese (P ¼ 0.006), overweight (Po0.001), normal weight range (Po0.001), or underweight (P ¼ 0.008), respectively.
Results
Preliminary analyses
Obese patients in both groups also were significantly younger than those classified as overweight (P ¼ 0.012 for no previous revascularization and P ¼ o0.001 for previously revascularized patients) and normal weight (P ¼ o0.001 for no previous revascularization and P ¼ o0.001 for previously revascularized patients), but not underweight. The only other difference that was statistically significant was that overweight patients who were previously revascularized were younger than those in the normal weight range. Thus, patients with class I and II obesity in this sample were substantially younger when they underwent revascularization, regardless of whether they had ever had a previous PCI or CABG, than overweight, normal weight range, or even underweight patients, even after adjustment for history of any previous revascularization and other known risk factors.
Long-term health status, repeat revascularization, and survival Stratified (by previous revascularization status) ANCOVA models that adjusted for significant differences in baseline status (eg, age, gender, diabetes, hypertension, and angina type) and baseline scores on the respective health status measure were used to examine the relationship between obesity and health status. Table 2 presents the long-term Impact of obesity on disease-specific health status WS Carlos Poston et al health status outcomes (ie, SAQ and SF-12) for PCI by BMI category at baseline and 12months.
Patients with previous revascularization history demonstrated similar recovery 12-month improvements in health status and quality of life regardless of BMI status. However, those with no previous revascularization history demonstrated weight status category differences on the SAQ-QOL (F ¼ 3.02; P ¼ 0.018) and SF-12 PCS (F ¼ 2.82; P ¼ 0.024) scales. Post hoc analysis revealed that underweight patients (ie, those with a BMI o20 kg/m 2 ) with no previous revascularization demonstrated significantly smaller improvements after PCI when compared to patients in all other BMI categories (Po0.001). For example, while patients in all other BMI groups experienced at least 25 point increases in the disease-specific quality of life, underweight patients only experienced an average increase of 13 points on the SAQ-QOL (see Figure 1 ), among those patients with both baseline and follow-up data.
There were no statistically significant differences in need for repeat revascularization within 12-months or 12-month survival by BMI status (see Table 3 ). The asterisks and bold indicate that the differences between BMI status groups was statistically significant at Po0.05. All models include adjustment for baseline questionnaire status, age, gender, marital status, smoking, hypertension, diabetes, and unstable angina. The bold indicate that the differences between BMI status groups was statistically significant at Po0.05.
Impact of obesity on disease-specific health status WS Carlos Poston et al
Adjusted multivariate logistic regression models (covariates included age, marital status, gender, smoking, diabetes, hypertension, and unstable angina) did not demonstrate a significant association between BMI category and 12-month mortality among patients with no previous history of revascularization (normal weight range is referent group; underweight OR ¼ 3. There also were no statistically significant differences in risk for repeat revascularization within 12 months after the index procedure. For patients with no previous history of PCI or CABG, the risk of a repeat procedure was OR ¼ 0.27, P ¼ 0.21 for underweight patients, OR ¼ 0.87, P ¼ 0.56 for overweight, OR ¼ 0.80, P ¼ 0. 40 
Discussion
Using a longitudinal cohort design, this study examined the relationship between BMI and disease-specific health status following PCI. Outcomes were assessed by generic (SF-12), and disease-specific measures (SAQ), need for repeat revascularization, and mortality. Obesity was not associated with any long-term outcomes (eg, survival, quality of life, or disease-specific health status) following PCI. In fact, overweight and obese patients appeared to benefit just as much from coronary revascularization as those patients with a normal BMI. In contrast, underweight patients (BMI o20 kg/ m 2 ) appeared to gain less quality of life benefit and reported poorer physical functioning 1-year following PCI. In addition, there was no association between obesity status and need for repeat revascularization or 12-month mortality. In fact, our results, while not statistically significant, demonstrated greater risk for underweight individuals, [22] [23] [24] and less for overweight and all classes of obesity, when compared to the normal weight range with regard to mortality risk. There was evidence that overweight and obese patients received PCI at an earlier age than normal weight patients, even among those with no previous history of revascularization. These results are similar to those reported by Suwaidi et al. 5 At least two possible explanations may account for this phenomenon. As others have suggested, obesity is an important risk factor for cardiovascular disease. 4, 44 In addition, obesity may worsen patients' perceptions of their health status for a given amount of cardiac stenoses such that obese patients require revascularization at an early point in the time course of their disease than more lean patients. Another possibility is that the efficacy of alternative treatment options such as antianginal medications, exercise, and diet alterations may be perceived by physicians as potentially less efficacious in the obese such that these patients are more readily referred for mechanical revascularization. Future studies that employ a broader patient population (ie, not a 
Repeat revascularization within 12-months (% yes) Impact of obesity on disease-specific health status WS Carlos Poston et al procedure-based cohort but rather an acute coronary syndrome population or an outpatient cohort of patients with angina) should examine whether obesity promotes earlier onset of coronary disease or significantly affects medical decisions regarding treatments for cardiovascular illness.
There are several limitations to this study. First, the patients were recruited from a single, high-volume facility that specializes in coronary care. The patients served by this medical facility were largely white, educated, and from relatively high socioeconomic backgrounds. Thus, it is unclear whether the results of this investigation would be generalizable to other facilities or patient groups. Second, we were not able to examine age of first myocardial infarction because those data were not available, so our results are not directly comparable to the Suwaidi et al 5 data. However, our models were stratified by previous revascularization history and the results were consistent with the Suwaidi et al' s   5 findings.
In addition, we were unable to ascertain weight at the follow-up. Since weight changes during the follow-up period could affect reported quality of life and function, future studies should attempt to assess weight status at both baseline and follow-up. Finally, while our follow-up for repeat procedures and survival was nearly 100%, we were less successful in completing follow-up for the health status measures on all surviving patients. Thus, our group with valid health status follow-up demonstrated some differences from those without follow-up that might have influenced our results. For example, those without health status followup measures were more likely to smoke and we have previously demonstrated that current smoking significantly attenuates health status and quality of life benefits associated with PCI. 45 Given the differences in smoking status among PCI patients without previous history of revascularization (ie, underweight patients in this group were significantly more likely to be current smokers), it is likely that our findings underestimate the impact of underweight on health status outcomes.
In conclusion, we found that overweight and all classes of obesity were not significant predictors of poor 12-month health status outcomes among patients who had undergone PCI. In fact, underweight status appeared to be a more important predictor of poor health status outcomes, although the results for repeat procedures and mortality were not statistically significant, and thus could have occurred due to chance. Therefore, the results of this study imply that clinicians' should not significantly alter their therapeutic recommendations for patients on the basis of overweight or obesity status.
